Leerink Partners Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating

Futu News16:32 · Ratings

Vertex Pharmaceuticals' Suzetrigine: A Promising Opioid Alternative in Pain Management

TipRanks15:27

Vertex Pharmaceuticals Is Maintained at Overweight by Piper Sandler

Dow JonesJan 27 23:08 · Ratings

Earnings Preview: Vertex Pharmaceuticals (VRTX) Q4 Earnings Expected to Decline

Zacks Jan 27 22:15

Piper Sandler Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Cuts Target Price to $533

Futu NewsJan 27 20:31 · Ratings

Press Release: Vertex to Announce Fourth Quarter and Full Year 2024 Financial Results on February 10

Dow JonesJan 27 20:30